Skip to content

house · Committee report

H. Rept. 118-620

AUTISM COLLABORATION, ACCOUNTABILITY, RESEARCH, EDUCATION, AND SUPPORT ACT OF 2024

2024-07-30

Committees

Associated legislation

Text

Purpose and Summary

The Autism Collaboration, Accountability, Research, Education, and Support (CARES) Act of 2024 reauthorizes and makes improvements to certain programs related to autism spectrum disorder, including the Developmental Disabilities Surveillance and Research Program; Autism education, early detection, and intervention; and the Interagency Autism Coordination Committee at currently appropriated levels for fiscal years 2025 through 2029.

Background and Need for Legislation

Autism affects an estimated 1 in 36 children in the United States.\1\ Behavioral signs of autism usually appear early in development, often as early as 12 to 18 months of age or earlier.\2\ Research shows that early intervention and therapies lead to positive outcomes later in life for individuals with autism.\3\ --------------------------------------------------------------------------- \1\Maenner MJ, Warren Z, Williams AR, et al. Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years--Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2020. MMWR Surveill Summ 2023;72 (No. SS-2):1-14. DOI:http://dx.doi.org/10.15585/mmwr.ss7202a1. \2\``When do children usually show symptoms of autism?,'' National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, January 31, 2017, https:// www.nichd.nih.gov/health/topics/autism/conditioninfo/symptoms-appear. \3\``Autism spectrum disorder (ASD), What is autism?,'' Autism Speaks, https://www.autismspeaks.org/what-is-autism. --------------------------------------------------------------------------- First signed into law in 2006, the CARES Act funds programs to directly improve the quality of lives of individuals with Autism, their families, and their caregivers. The current authorization for these programs expires September 30, 2024. H.R. 7213 would support and enhance existing programs related to autism spectrum disorder, including improving research coordination and research into evidence-based interventions, ensuring research is reflective of the entire population of individuals with autism spectrum disorder, continuing surveillance and early identification programs, and facilitating increased and robust opportunities for public input. The legislation also strengthens existing education and training programs for providers, and requires updated strategic plans and progress reports, as well as an annual budget plan to carry out such strategic planning.

Committee Action

On February 14, 2024, the Subcommittee on Health held a hearing on H.R. 7213. The title of the hearing was ``Legislative Proposals to Support Patients and Caregivers.'' The Subcommittee received testimony from: Andy Shih, PhD, Chief Science Officer, Autism Speaks; Corey Feist, JD, MBA, Co-Founder and CEO, Dr. Lorna Breen Heroes' Foundation; Joanne Pike, DrPH, President and CEO, Alzheimer's Association; Gordon Tomaselli, MD, Former President, American Heart Association; Marilyn and Stanley M. Katz Dean, Emeritus and Professor of Medicine, Albert Einstein College of Medicine; Adjunct Professor of Medicine, Johns Hopkins University School of Medicine; Michelle Whitten, President, CEO, and Co- Founder, Global Down Syndrome Foundation; Randy Strozyk, President, American Ambulance Association; and Christina Annunziata, MD, PhD, Senior Vice President of Extramural Discovery Science, American Cancer Society. On May 16, 2024, the Subcommittee on Health met in open markup session and forwarded H.R. 7213, as amended, to the full Committee by a record vote of 22 yeas to 0 nays. On June 12, 2024, the full Committee on Energy and Commerce met in open markup session and ordered H.R. 7213, as amended, favorably reported to the House by a record vote of 42 yeas and 0 nays.

Committee Votes

Clause 3(b) of rule XIII requires the Committee to list the record votes on the motion to report legislation and amendments thereto. The following reflects the record votes taken during the Committee consideration: [GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT] Oversight Findings and Recommendations Pursuant to clause 2(b)(1) of rule X and clause 3(c)(1) of rule XIII, the Committee held a hearing and made findings that are reflected in this report. New Budget Authority, Entitlement Authority, and Tax Expenditures Pursuant to clause 3(c)(2) of rule XIII, the Committee finds that H.R. 7213 would result in no new or increased budget authority, entitlement authority, or tax expenditures or revenues.

Congressional Budget Office Estimate

Pursuant to clause 3(c)(3) of rule XIII, at the time this report was filed, the cost estimate prepared by the Director of the Congressional Budget Office pursuant to section 402 of the Congressional Budget Act of 1974 was not available. Federal Mandates Statement The Committee adopts as its own the estimate of Federal mandates prepared by the Director of the Congressional Budget Office pursuant to section 423 of the Unfunded Mandates Reform Act. Statement of General Performance Goals and Objectives Pursuant to clause 3(c)(4) of rule XIII, the general performance goal or objective of this legislation is to reauthorize and make improvements to activities and programs relating to autism spectrum disorder. Duplication of Federal Programs Pursuant to clause 3(c)(5) of rule XIII, no provision of H.R. 7213 is known to be duplicative of another Federal program, including any program that was included in a report to Congress pursuant to section 21 of Public Law 111-139 or the most recent Catalog of Federal Domestic Assistance. Related Committee and Subcommittee Hearings Pursuant to clause 3(c)(6) of rule XIII, the following related hearing was used to develop or consider H.R. 7213: On February 14, 2024, the Subcommittee on Health held a hearing on H.R. 7213. The title of the hearing was ``Legislative Proposals to Support Patients and Caregivers.'' The Subcommittee received testimony from: Andy Shih, PhD, Chief Science Officer, Autism Speaks; Corey Feist, JD, MBA, Co-Founder and CEO, Dr. Lorna Breen Heroes' Foundation; Joanne Pike, DrPH, President and CEO, Alzheimer's Association; Gordon Tomaselli, MD, Former President, American Heart Association; Marilyn and Stanley M. Katz Dean, Emeritus and Professor of Medicine, Albert Einstein College of Medicine; Adjunct Professor of Medicine, Johns Hopkins University School of Medicine; Michelle Whitten, President, CEO, and Co-Founder, Global Down Syndrome Foundation; Randy Strozyk, President, American Ambulance Association; and Christina Annunziata, MD, PhD, Senior Vice President of Extramural Discovery Science, American Cancer Society. Committee Cost Estimate Pursuant to clause 3(d)(1) of rule XIII, the Committee adopts as its own the cost estimate prepared by the Director of the Congressional Budget Office pursuant to section 402 of the Congressional Budget Act of 1974. At the time this report was filed, the estimate was not available. Earmark, Limited Tax Benefits, and Limited Tariff Benefits Pursuant to clause 9(e), 9(f), and 9(g) of rule XXI, the Committee finds that H.R. 7213 contains no earmarks, limited tax benefits, or limited tariff benefits. Advisory Committee Statement No advisory committees within the meaning of section 5(b) of the Federal Advisory Committee Act were created by this legislation. Applicability to Legislative Branch The Committee finds that the legislation does not relate to the terms and conditions of employment or access to public services or accommodations within the meaning of section 102(b)(3) of the Congressional Accountability Act. Section-by-Section Analysis of the Legislation Section 1. Short title Section 1 provides that the Act may be cited as the ``Autism Collaboration, Accountability, Research, Education, and Support Act of 2024,'' or the ``Autism CARES Act of 2024''. Section 2. National Institutes of Health activities Section 2 expands and improves coordination of research related to autism spectrum disorder within the National Institutes of Health (NIH), including by ensuring such research reflects the entire population of individuals with autism spectrum disorder, and is informed by opportunities for public input. This section also increases the minimum number of currently existing centers of excellence from five to six. Section 3. Programs relating to autism Section 3 enhances existing education, early detection, and intervention training efforts by including parents and guardians as eligible participants and ensuring such efforts will appropriately serve patients with autism spectrum disorder. This section also requires the Interagency Autism Coordinating Committee (IACC) to develop updated strategic plans and reports, including progress made to implement the recommendations and strategies. In addition, this section requires a professional judgment budget for carrying out the strategic plan. Changes in Existing Law Made by the Bill, as Reported In compliance with clause 3(e) of rule XIII of the Rules of the House of Representatives, changes in existing law made by the bill, as reported, are shown as follows (existing law proposed to be omitted is enclosed in black brackets, new matter is printed in italics, and existing law in which no change is proposed is shown in roman): PUBLIC HEALTH SERVICE ACT * * * * * * * TITLE III--GENERAL POWERS AND DUTIES OF PUBLIC HEALTH SERVICE * * * * * * * PART R--PROGRAMS RELATING TO AUTISM SEC. 399AA. DEVELOPMENTAL DISABILITIES SURVEILLANCE AND RESEARCH PROGRAM. (a) Autism Spectrum Disorder and Other Developmental Disabilities.-- (1) In general.--The Secretary, acting through the Director of the Centers for Disease Control and Prevention, may award grants or cooperative agreements to eligible entities for the collection, analysis, and reporting of State epidemiological data for children and adults with autism spectrum disorder and other developmental disabilities. An eligible entity shall assist with the development and coordination of State autism spectrum disorder and other developmental disability surveillance efforts within a region. In making such awards, the Secretary may provide direct technical assistance in lieu of cash. (2) Data standards.--In submitting epidemiological data to the Secretary pursuant to paragraph (1), an eligible entity shall report data according to guidelines prescribed by the Director of the Centers for Disease Control and Prevention, after consultation with relevant State, local, and Tribal public health officials, private sector developmental disability researchers, and advocates for individuals with autism spectrum disorder and other developmental disabilities. (3) Eligibility.--To be eligible to receive an award under paragraph (1), an entity shall be a public or nonprofit private entity (including a health department of a State or a political subdivision of a State, a university, any other educational institution, an Indian tribe, or a tribal organization), and submit to the Secretary an application at such time, in such manner, and containing such information as the Secretary may require. (b) Centers of Excellence in Autism Spectrum Disorder Epidemiology.-- (1) In general.--The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall, subject to the availability of appropriations, award grants or cooperative agreements for the establishment or support of regional centers of excellence in autism spectrum disorder and other developmental disabilities epidemiology for the purpose of collecting and analyzing information on the number, incidence, correlates, [and causes] causes, and life course of autism spectrum disorder and other developmental disabilities for children and adults. (2) Requirements.--To be eligible to receive a grant or cooperative agreement under paragraph (1), an entity shall submit to the Secretary an application containing such agreements and information as the Secretary may require, including an agreement that the center to be established or supported under the grant or cooperative agreement shall operate in accordance with the following: (A) The center will collect, analyze, and report autism spectrum disorder and other developmental disability data according to guidelines prescribed by the Director of the Centers for Disease Control and Prevention, after consultation with State, local, and Tribal public health officials, private sector developmental disability researchers, advocates for individuals with autism spectrum disorder, and advocates for individuals with other developmental disabilities. (B) The center will develop or extend an area of special research expertise (including genetics, epigenetics, and epidemiological research related to environmental exposures), immunology, and other relevant research specialty areas. (C) The center will identify eligible cases and controls through its surveillance system and conduct research into factors which may cause or increase the risk of autism spectrum disorder and other developmental disabilities. (c) Federal Response.--The Secretary shall coordinate the Federal response to requests for assistance from State health, mental health, and education department officials regarding potential or alleged autism spectrum disorder or developmental disability clusters. (d) Definitions.--In this part: (1) Indian tribe; tribal organization.--The terms ``Indian tribe'' and ``tribal organization'' have the meanings given such terms in section 4 of the Indian Health Care Improvement Act. (2) Other developmental disabilities.--The term ``other developmental disabilities'' has the meaning given the term ``developmental disability'' in section 102(8) of the Developmental Disabilities Assistance and Bill of Rights Act of 2000 (42 U.S.C. 15002(8)). (3) State.--The term ``State'' means each of the several States, the District of Columbia, the Commonwealth of Puerto Rico, American Samoa, Guam, the Commonwealth of the Northern Mariana Islands, the Virgin Islands, and the Trust Territory of the Pacific Islands. (e) Sunset.--This section shall not apply after September 30, [2024] 2029. SEC. 399BB. AUTISM EDUCATION, EARLY DETECTION, AND INTERVENTION. (a) Purpose.--It is the purpose of this section-- (1) to increase awareness, reduce barriers to screening and diagnosis, promote evidence-based interventions for individuals with autism spectrum disorder and other developmental disabilities, and train professionals to utilize valid and reliable screening tools to diagnose or rule out and provide evidence-based interventions for individuals with autism spectrum disorder and other developmental disabilities across their lifespan; and (2) to conduct activities under this section with a focus on an interdisciplinary approach (as defined in programs developed under section 501(a)(2) of the Social Security Act) that will also focus on specific issues for children who are not receiving an early diagnosis and [subsequent interventions] subsequent interventions and services. (b) In General.--The Secretary shall, subject to the availability of appropriations, establish and evaluate activities to-- (1) provide [culturally competent information] culturally and linguistically responsive information and education on autism spectrum disorder and other developmental disabilities to increase public awareness of developmental milestones; (2) [promote research] promote research, which may include community-based participatory research, into the development and validation of reliable [screening tools] screening and diagnostic tools for individuals with autism spectrum disorder and other developmental disabilities and disseminate information regarding those [screening tools] screening and diagnostic tools; (3) promote early screening of individuals [at higher risk] at increased likelihood for autism spectrum disorder and other developmental disabilities as early as practicable, given evidence-based screening techniques and interventions; (4) promote evidence-based screening techniques and interventions for individuals with autism spectrum disorder and other developmental disabilities across their lifespan, which may include such individuals utilizing parents and guardians trained to provide interventions, services, and supports; (5) increase the number of individuals who are able to confirm or rule out a diagnosis of autism spectrum disorder and other developmental disabilities; (6) increase the number of individuals able to provide evidence-based interventions for individuals diagnosed with autism spectrum disorder or other developmental disabilities; and (7) promote the use of evidence-based interventions for individuals at higher risk for autism spectrum disorder and other developmental disabilities as early as practicable. (c) Information and Education.-- (1) In general.--In carrying out subsection (b)(1), the Secretary, in collaboration with the Secretary of Education and the Secretary of Agriculture, shall, subject to the availability of appropriations, provide [culturally competent information] culturally and linguistically responsive information regarding autism spectrum disorder and other developmental disabilities, risk factors, characteristics, identification, diagnosis or rule out, and evidence-based interventions to meet the needs of individuals with autism spectrum disorder and other developmental disabilities across their lifespan and the needs of their families through-- (A) Federal programs, including-- (i) the Head Start program; (ii) the Early Start program; (iii) the Healthy Start program; (iv) programs under the Child Care and Development Block Grant Act of 1990; (v) programs under title XIX of the Social Security Act (particularly the Medicaid Early and Periodic Screening, Diagnosis and Treatment Program); (vi) the program under title XXI of the Social Security Act (the State Children's Health Insurance Program); (vii) the program under title V of the Social Security Act (the Maternal and Child Health Block Grant Program); (viii) the program under parts B and C of the Individuals with Disabilities Education Act; (ix) the special supplemental nutrition program for women, infants, and children established under section 17 of the Child Nutrition Act of 1966 (42 U.S.C. 1786); and (x) the State grant program under the Rehabilitation Act of 1973. (B) State licensed child care facilities; and (C) other community-based organizations or points of entry for individuals with autism spectrum disorder and other developmental disabilities to receive services. (2) Lead agency.-- (A) Designation.--As a condition on the provision of assistance or the conduct of activities under this section with respect to a State, the Secretary may require the Governor of the State-- (i) to designate a public agency as a lead agency to coordinate the activities provided for under paragraph (1) in the State at the State level; and (ii) acting through such lead agency, to make available to individuals and their family members, guardians, [advocates,] advocates, self-advocates, or authorized representatives; providers; and other appropriate individuals in the State, comprehensive [culturally competent information] culturally and linguistically responsive information about State and local resources regarding autism spectrum disorder and other developmental disabilities, risk factors, characteristics, identification, diagnosis or rule out, available services and supports (which may include respite care for caregivers of individuals with autism spectrum disorder or other developmental disabilities), and evidence-based interventions. (B) Requirements of agency.--In designating the lead agency under subparagraph (A)(i), the Governor shall-- (i) select an agency that has demonstrated experience and expertise in-- (I) autism spectrum disorder and other developmental disability issues; and (II) developing, implementing, conducting, and administering programs and delivering education, information, and referral services (including technology- based cur

Source: https://api.congress.gov/v3/committee-report/118/hrpt/620